Quest Diagnostics
DGX
#861
Rank
C$40.51 B
Marketcap
C$367.09
Share price
1.60%
Change (1 day)
41.93%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

Number of shares outstanding for Quest Diagnostics (DGX)

Number of shares outstanding as of November 2026 : 110,000,000

According to Quest Diagnostics 's latest financial reports and stock price the company's current number of shares outstanding is 110,000,000. At the end of 2024 the company had 111,000,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Quest Diagnostics from 2005 to 2024

Shares Outstanding at the end of each year

Year Shares Outstanding Change
20240.11 B-0.89%
20230.11 B-0.88%
20220.11 B-7.38%
20210.12 B-9.63%
20200.13 B0.75%
20190.13 B-1.47%
20180.13 B0%
20170.13 B-1.45%
20160.13 B-3.5%
20150.14 B-1.38%
20140.14 B-0.68%
20130.14 B-8%
20120.15 B0.57%
20110.15 B-8.89%
20100.17 B-6.43%
20090.18 B-5.06%
20080.19 B0.82%
20070.19 B-1.92%
20060.19 B-2.72%
20050.20 B

Shares Outstanding for similar companies or competitors

Company Shares Outstanding differencediff. Country
LabCorp
LH
81,100,000-26.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
62,908,800-42.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Psychemedics
PMD
5,894,000-94.64%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
128,587,000 16.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
206,346,000 87.59%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Enzo Biochem
ENZB
52,403,000-52.36%๐Ÿ‡บ๐Ÿ‡ธ USA